Point72 (DIFC)’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.1K | Sell |
2,176
-19,269
| -90% | -$701K | ﹤0.01% | 515 |
|
|
2025
Q1 | $777K | Buy |
21,445
+2,825
| +15% | +$102K | 0.03% | 203 |
|
|
2024
Q4 | $783K | Buy |
18,620
+4,103
| +28% | +$173K | 0.03% | 194 |
|
|
2024
Q3 | $806K | Buy |
14,517
+11,848
| +444% | +$658K | 0.03% | 216 |
|
|
2024
Q2 | $110K | Sell |
2,669
-7,383
| -73% | -$303K | ﹤0.01% | 451 |
|
|
2024
Q1 | $469K | Buy |
+10,052
| New | +$469K | 0.01% | 344 |
|